Biotechnology · Healthcare
Chief Accounting Officer
2020-10-13–present
Chief Accounting Officer
Heron Therapeutics, Inc. (HRTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Heron Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get HRTX alertsLisa Peraza is recorded as Chief Accounting Officer at Heron Therapeutics, Inc. (HRTX) since October 13, 2020. The newest filing on record that lists Lisa Peraza as Chief Accounting Officer at Heron Therapeutics, Inc. (HRTX) is dated May 1, 2023. The proxy statement of Heron Therapeutics, Inc. reports total compensation of $796,755 for Lisa Peraza in fiscal 2021, including a base salary of $339,900. Disclosed compensation is on record for 2 fiscal years. Heron Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Heron Therapeutics, Inc. includes Craig Collard (CEO and Board Member), Adam Morgan (Chairman and Board Member), Ira Duarte (CFO and Chief Accounting Officer) and 7 others.
2020-10-13–present
Last confirmed May 1, 2023
Start not stated–2021-04-22
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Chief Accounting Officer
2020-10-13–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Heron Therapeutics, Inc. (HRTX) | Vice President, Chief Accounting Officer | $339,900 | $796,755 |
| 2020 | Heron Therapeutics, Inc. (HRTX) | Vice President, Chief Accounting Officer | $328,805 | $1,578,739 |
No call appearances or filed executive changes recorded yet.